POET Technologies: A Governance Crisis Collides With a Production Timeline

POET shares drop 35% in a month on class-action lawsuit and Celestial AI order cancellation, but long-term operational targets remain intact with $830M raised.

The numbers tell a brutal short-term story. POET Technologies shares closed at €6.09 on Friday, down 8.83% on the day and 34.94% over the past month. The stock now sits 67.68% below its May high of €18.84. But the headline figures mask a more nuanced picture: on a twelve-month basis, the shares are still up 15.56%. That gap between long-term gain and near-term collapse is the hallmark of a story stock that ran too far and is now repricing legal and dilution risk — not fundamental operational failure.

The Legal Trigger That Broke a Key Customer Relationship

The immediate catalyst for the sell-off is a class-action lawsuit that accuses POET of misrepresenting its US tax status as a potential Passive Foreign Investment Company, alongside allegations that a senior manager violated a confidentiality agreement. The fallout was swift and severe: Celestial AI, a Marvell affiliate, cancelled all orders with POET, triggering an intraday crash of roughly 45% to 47% in late April.

The lawsuit escalated again on Friday, with the shares dropping another 9.69% as investors digested the implications. The core allegation — that a confidentiality breach cost the company its most visible customer — strikes at the heart of investor trust.

Separating Legal Noise From Operating Reality

The legal drama, however, should not be conflated with the operational trajectory. POET's 2026 annual general meeting confirmed all board nominees and reappointed Davidson & Company as auditor with broad shareholder support. Management has reaffirmed that production of optical engines remains on track for the second half of 2026, with capacity targets of up to one million units per month by the end of 2027.

The company has raised $830 million in equity over the past twelve months, with potential for an additional $661 million through warrants. Capital expenditure of roughly $50 million is planned for production equipment by year-end 2026. Management also points to more than ten active customer discussions that could generate annual revenues exceeding $100 million.

This is not the profile of a company whose technology thesis has collapsed. It is a company whose aggressive, equity-financed capacity expansion has collided with a governance scandal — one that scared off a key customer and triggered investor lawsuits.

The Bull Case: Overdone Panic Meets a Solid Balance Sheet

The argument for patience rests on POET's cash position, which provides a buffer to execute the production ramp even while operating losses continue. With a market capitalisation of €417.74 million, the stock has already priced in considerable scepticism relative to its May peak.

Technical indicators offer a mixed signal. The RSI of 36.2 is approaching oversold territory without confirming a trend reversal. The distance to the 200-day moving average is a relatively narrow 11.04%, suggesting the medium-term uptrend is not entirely broken. By contrast, the gap to the 50-day line is far wider, underscoring that short-term momentum remains firmly negative.

Supporters of a recovery point to the fundamental value of POET's optical interposer intellectual property in the growing AI data-centre market. The semiconductor industry continues to seek more efficient packaging solutions, and POET's technology remains relevant — provided the company can convert its prototypes into binding contracts with other Tier-1 AI hardware providers.

The Bear Case: Structural Damage That Dilution Can't Fix

The counter-argument carries more weight. The stock now trades 36.85% below its 50-day moving average of €9.60, a stark indicator of the sentiment shift in recent weeks. The annualised 30-day volatility of over 93% reflects genuine uncertainty about the path ahead.

The real risk is structural damage to the business model. If major industry players — particularly Marvell affiliates — avoid POET due to confidentiality concerns, the path to Tier-1 customers could be effectively blocked. The company's lack of meaningful revenue, combined with high net losses, leaves it vulnerable to further equity dilution beyond what is already planned.

Should the stock retest its 52-week low of €3.40, the downside from current levels would be substantial. That scenario becomes more likely if broader concerns about AI investment spending continue to weigh on the Nasdaq.

The Technical Crossroads

For now, the stock remains below its 200-day moving average of €6.85, a level that is likely to act as resistance rather than support during any recovery attempts. A sustained move above that threshold would be needed to shift the technical picture from bearish to neutral.

The next concrete catalyst will be the quarterly results, expected in late summer or early autumn 2026. Management will need to address both the status of the lawsuit and provide a timeline for new revenue-generating contracts. Until then, the shares are caught between a production story that remains intact and a legal overhang that shows no signs of lifting.